# Hologic Acquires Reveal Genomics for Breast Cancer Diagnostics

> Hologic to buy Reveal Genomics, expanding breast cancer testing for women.
- Title: Hologic Acquires Reveal Genomics for Breast Cancer Diagnostics
- Summary: Hologic to buy Reveal Genomics, expanding breast cancer testing for women. Hologic acquires Reveal Genomics to expand precision oncology diagnostics for…
- Keywords: hologic, reveal genomics, breast cancer, oncology diagnostics, precision medicine, her2dx test, diagnostic solutions, money, business, Acquires, Reveal, Genomics
- Source: Financialpost — https://financialpost.com/pmn/business-wire-news-releases-pmn/hologic-signs-definitive-agreement-to-acquire-reveal-genomics
- Read time: 1 min
- Topics: hologic, reveal genomics, breast cancer, oncology diagnostics, precision medicine, her2dx test, diagnostic solutions, money, business
## Hologic Announces Acquisition
Hologic, a global leader in women’s health, signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain.
## Reveal Genomics’ Role in Breast Cancer
Reveal Genomics develops advanced genomic diagnostic tests to help personalized cancer treatment, including its HER2DX test for HER2-positive breast cancer.
## Hologic’s Existing Diagnostics
Hologic’s Breast Cancer Index ® (BCI) test helps inform decisions regarding extended endocrine therapy for HR+ early-stage breast cancer.
## Strategic Expansion
The combination of Hologic’s testing with Reveal Genomics’ portfolio expands diagnostic oncology solutions to help more women with breast cancer.
## CEO Statements
Vitor Rocha, CEO of Hologic’s Diagnostic Solutions, said Reveal Genomics’ portfolio complements Hologic’s oncology offering and expands treatment decision capabilities.
## Reveal Genomics’ Vision
Patricia Villagrasa-Gonzalez, CEO and co-founder of Reveal Genomics, stated joining Hologic accelerates their mission to improve breast cancer treatment decisions globally.
## Regulatory Conditions
Completion of the acquisition requires Spanish regulatory approval and other customary closing conditions.
## Key takeaway

Hologic acquires Reveal Genomics to expand precision oncology diagnostics for breast cancer treatment decisions.